Go Pro

Xeris Biopharma (XERS) Institutional Ownership

Xeris Biopharma logo
$8.16 -0.18 (-2.16%)
Closing price 07/13/2026 04:00 PM Eastern
Extended Trading
$8.12 -0.04 (-0.47%)
As of 04:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for Xeris Biopharma (NASDAQ:XERS)

Current
Institutional Ownership
Percentage
42.75%
Number of
Institutional Buyers
(last 12 months)
152
Total
Institutional Inflows
(last 12 months)
$180.10M
Number of
Institutional Sellers
(last 12 months)
75
Total
Institutional Outflows
(last 12 months)
$198.48M
Get XERS Insider Trade Alerts

Want to know when executives and insiders are buying or selling Xeris Biopharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

XERS Institutional Buying and Selling by Quarter

Xeris Biopharma Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
7/8/2026 Apella Capital LLC215,897$1.71M0.0%-8.5%0.125%
5/19/2026Bank of America Corp DE874,397$5.07M0.0%+21.8%0.506%
5/19/2026Janus Henderson Group PLC295,489$1.71M0.0%+322.8%0.171%
5/18/2026California State Teachers Retirement System180,339$1.05M0.0%+19.3%0.104%
5/18/2026Royal Bank of Canada43,610$253K0.0%+12.9%0.025%
5/16/2026The Manufacturers Life Insurance Company 72,804$422K0.0%+59.0%0.042%
5/16/2026Quantinno Capital Management LP30,971$180K0.0%+25.4%0.018%
5/15/2026Rice Hall James & Associates LLC251,066$1.46M0.1%N/A0.145%
5/15/2026Granahan Investment Management LLC921,854$5.35M0.3%-24.6%0.534%
5/15/2026Entropy Technologies LP20,432$119K0.0%N/A0.012%
5/14/2026Healthcare of Ontario Pension Plan Trust Fund464,084$2.69M0.0%-13.7%0.269%
5/14/2026Renaissance Technologies LLC452,860$2.63M0.0%-26.9%0.262%
5/14/2026Arrowstreet Capital Limited Partnership133,760$776K0.0%-37.7%0.077%
5/14/2026Knott David M Jr1,060,000$6.15M3.6%+9.3%0.614%
5/14/2026Sei Investments Co.579,210$3.36M0.0%+45.0%0.336%
5/14/2026State of Wyoming10,420$60K0.0%-75.5%0.006%
5/13/2026Cetera Investment Advisers44,397$258K0.0%+14.9%0.026%
5/7/2026AlphaCentric Advisors LLC45,886$266K0.3%+5.7%0.027%
5/7/2026KBC Group NV4,573$27K0.0%N/A0.003%
5/7/2026Swiss National Bank328,300$1.90M0.0%+3.1%0.190%
5/5/2026Bank of New York Mellon Corp426,285$2.47M0.0%-1.8%0.247%
5/4/2026Emerald Mutual Fund Advisers Trust207,543$1.20M0.1%N/A0.120%
5/4/2026Empirical Financial Services LLC d.b.a. Empirical Wealth Management13,650$79K0.0%-15.1%0.008%
5/4/2026Principal Financial Group Inc.208,507$1.21M0.0%+38.5%0.121%
5/4/2026Chicago Partners Investment Group LLC13,493$81K0.0%N/A0.008%
4/30/2026Hsbc Holdings PLC31,175$183K0.0%N/A0.018%
4/29/2026R Squared Ltd13,802$80K0.0%N/A0.008%
4/27/2026Y Intercept Hong Kong Ltd161,793$938K0.0%+78.5%0.094%
4/25/2026Strs Ohio17,600$102K0.0%-73.1%0.010%
4/22/2026Pictet Asset Management Holding SA29,999$174K0.0%+29.3%0.017%
4/20/2026 Apella Capital LLC235,897$1.50M0.0%-4.1%0.137%
4/16/2026SG Americas Securities LLC121,911$707K0.0%+10.6%0.071%
3/9/2026Corient Private Wealth LLC10,734$84K0.0%N/A0.006%
2/19/2026Invesco Ltd.112,130$880K0.0%-80.8%0.068%
2/19/2026Corient Private Wealth LLC10,734$84K0.0%N/A0.006%
2/18/2026VARCOV Co.31,005$243K0.1%N/A0.019%
2/18/2026Voloridge Investment Management LLC811,129$6.37M0.0%-21.6%0.489%
2/18/2026Virtus Investment Advisers LLC37,102$291K0.1%+44.1%0.022%
2/18/2026Tudor Investment Corp ET AL22,186$174K0.0%-41.6%0.013%
2/18/2026Millennium Management LLC859,051$6.74M0.0%+63.7%0.518%
Read now. Do not delete. You’ve been warned. (Ad)

Three Nobel Prize Winners expose this once-in-a-generation wealth shift: “Don’t Say I Didn’t Warn You” Porter Stansberry exposes how the convergence of three immense forces is about to rewrite everything about the American way of life: how you work, save, invest… it’s all about to change.tc pixel

Don’t be left behind. Click here now.
2/18/2026Man Group plc47,775$375K0.0%N/A0.029%
2/18/2026IHT Wealth Management LLC263,531$2.07M0.1%+2.1%0.159%
2/18/2026Ishara Investments LP800,000$6.28M7.3%N/A0.482%
2/18/2026Engineers Gate Manager LP89,404$702K0.0%-18.7%0.054%
2/18/20269823 Capital L.P.24,917$196K0.1%N/A0.015%
2/17/2026Schonfeld Strategic Advisors LLC234,723$1.84M0.0%-22.9%0.141%
2/17/2026AQR Capital Management LLC957,579$7.52M0.0%-2.6%0.577%
2/17/2026Jain Global LLC11,114$87K0.0%N/A0.007%
2/17/2026Trexquant Investment LP213,581$1.68M0.0%-6.9%0.129%
2/17/2026Jump Financial LLC341,068$2.68M0.0%-43.5%0.206%
2/17/2026Price T Rowe Associates Inc. MD173,463$1.36M0.0%+4.0%0.105%
2/17/2026Osaic Holdings Inc.52,285$410K0.0%+29.6%0.032%
2/17/2026Diadema Partners LP170,568$1.34M0.2%+128.2%0.103%
2/17/2026Russell Investments Group Ltd.364,786$2.86M0.0%+45.1%0.220%
2/17/2026Granahan Investment Management LLC1,223,404$9.60M0.4%+249.4%0.737%
2/17/2026Kemnay Advisory Services Inc.8,480$67K0.0%N/A0.005%
2/17/2026State of Wisconsin Investment Board357,453$2.81M0.0%+2.0%0.215%
2/17/2026Royal Bank of Canada38,636$304K0.0%+6.5%0.023%
2/17/2026Persistent Asset Partners Ltd45,609$358K0.2%+165.1%0.027%
2/17/2026Faithward Advisors LLC106,730$838K0.1%N/A0.064%
2/16/2026Squarepoint Ops LLC482,832$3.79M0.0%-28.9%0.291%
2/16/2026Truvestments Capital LLC8,118$64K0.0%+96.1%0.005%
2/16/2026Healthcare of Ontario Pension Plan Trust Fund537,483$4.22M0.0%+111.6%0.324%
2/16/2026Kennedy Capital Management LLC1,213,969$9.53M0.2%+0.2%0.732%
2/16/2026Barclays PLC362,751$2.85M0.0%+4.6%0.219%
2/16/2026Aigen Investment Management LP12,262$96K0.0%-35.9%0.007%
2/13/2026Kestra Advisory Services LLC3,192$25K0.0%N/A0.002%
2/13/2026The Manufacturers Life Insurance Company 45,801$360K0.0%-8.7%0.028%
2/13/2026Quarry LP80,000$628K0.1%-3.0%0.048%
2/13/2026Essex Investment Management Co. LLC734,532$5.77M0.9%-2.1%0.443%
2/13/2026Rafferty Asset Management LLC33,689$264K0.0%+93.5%0.020%
2/13/2026Charles Schwab Investment Management Inc.1,403,824$11.02M0.0%-3.0%0.846%
2/13/2026State Street Corp4,116,924$32.32M0.0%+10.1%2.481%
2/13/2026Ieq Capital LLC86,520$679K0.0%-19.9%0.052%
2/13/2026Dynamic Technology Lab Private Ltd17,200$135K0.0%N/A0.010%
2/13/2026Caitong International Asset Management Co. Ltd7,501$59K0.2%+9,276.3%0.005%
2/13/2026UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC651,445$5.11M0.0%+255.1%0.393%
2/13/2026Wells Fargo & Company MN170,796$1.34M0.0%+75.7%0.103%
2/13/2026Castleark Management LLC445,950$3.50M0.1%N/A0.269%
2/12/2026HRT Financial LP332,326$2.61M0.0%+358.1%0.200%
2/12/2026MetLife Investment Management LLC81,594$641K0.0%-6.6%0.049%
2/12/2026Cibc World Markets Corp10,158$80K0.0%N/A0.006%
2/12/2026Renaissance Technologies LLC619,660$4.86M0.0%-61.8%0.373%
2/12/2026EntryPoint Capital LLC68,083$534K0.2%+28.4%0.041%
2/12/2026Integrated Quantitative Investments LLC66,170$519K0.1%N/A0.040%
2/12/2026Federated Hermes Inc.854,888$6.71M0.0%+21.4%0.515%
2/12/2026AlphaCentric Advisors LLC43,392$341K0.3%N/A0.026%
2/12/2026Informed Momentum Co LLC80,154$629K0.1%-86.7%0.048%
2/12/2026Rosalind Advisors Inc.2,111,700$16.58M6.1%+17.6%1.273%
2/12/2026Campbell & CO Investment Adviser LLC47,454$373K0.0%-54.2%0.029%
Gates. Google. The Pentagon. (Ad)

Bill Gates wrote a $100 million check. Google signed a 15-year contract. The Pentagon named it their top energy priority. All three are backing the same company - and the same energy source that holds 140 times global electricity demand. Last year a drilling crew cracked through three miles of solid rock in 16 days - the government had projected 64. On August 18th, Washington is handing this technology a tax credit advantage that solar and wind no longer receive.tc pixel

See the company Gates, Google, and the Pentagon are all backing
2/12/2026Knott David M Jr970,000$7.61M3.5%-4.4%0.585%
2/12/2026Swiss National Bank318,400$2.50M0.0%+2.6%0.192%
2/12/2026Nuveen LLC2,806,806$22.03M0.0%-0.7%1.692%
2/11/2026Janney Montgomery Scott LLC24,450$192K0.0%-6.7%0.015%
2/11/2026Deutsche Bank AG940,592$7.38M0.0%-40.0%0.567%
2/11/2026Fox Run Management L.L.C.26,174$205K0.0%N/A0.016%
2/11/2026Cerity Partners LLC29,578$232K0.0%-4.7%0.018%
2/11/2026LPL Financial LLC84,861$666K0.0%+154.8%0.051%
2/11/2026Franklin Resources Inc.121,428$953K0.0%+11.3%0.073%
2/11/2026CenterBook Partners LP1,391,590$10.92M0.5%+99.3%0.839%


XERS Institutional Ownership - Frequently Asked Questions

During the previous two years, 229 institutional investors and hedge funds held shares of Xeris Biopharma. The most heavily invested institutionals were Vanguard Group Inc. ($87.82M), Geode Capital Management LLC ($33.57M), State Street Corp ($32.32M), Qube Research & Technologies Ltd ($26.66M), Nuveen LLC ($22.03M), Rosalind Advisors Inc. ($16.58M), and Parkman Healthcare Partners LLC ($14.58M).Learn more on Xeris Biopharma's institutional investors.

42.75% of Xeris Biopharma's stock is owned by institutional investors. Learn more on XERS's institutional investor holdings.

Of the 205 institutional investors that purchased Xeris Biopharma's stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Nuveen LLC ($2.23M), CenterBook Partners LP ($1.82M), Walleye Capital LLC ($1.81M), Vanguard Group Inc. ($1.71M), Connor Clark & Lunn Investment Management Ltd. ($1.70M), Parkman Healthcare Partners LLC ($1.68M), and UBS Group AG ($1.55M).

Institutional investors have bought a total of 25,858,004 shares in the last 24 months. This purchase volume represents approximately $180.10M in transactions.

Of the 75 institutional investors that sold Xeris Biopharma's stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Deerfield Management Company L.P. ($10.40M), Millennium Management LLC ($2.41M), Invesco Ltd. ($1.41M), JPMorgan Chase & Co. ($1.35M), UBS Group AG ($1.18M), Renaissance Technologies LLC ($1.17M), and CenterBook Partners LP ($896.03K).

Institutional investors have sold a total of 26,321,182 shares in the last 24 months. This volume of shares sold represents approximately $198.48M in transactions.



This page (NASDAQ:XERS) was last updated on 7/14/2026 by MarketBeat.com Staff.
From Our Partners